BJL
HURA

Brighton Jones LLC’s TuHURA Biosciences HURA Stock Holding History

Brighton Jones LLC’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Sell
47,010
-1,575
-3% -$3.67K ﹤0.01% 1304
2026
Q1 		$87K Buy
+48,585
New +$59.5K ﹤0.01% 1134
2025
Q4 		– Sell
-27,735
Closed -$68.8K – 1015
2025
Q3 		$68.8K Buy
+27,735
New +$73K ﹤0.01% 1000

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brighton Jones LLC's HURA Position: Q2 2026 in Review

Brighton Jones LLC reduced its TuHURA Biosciences (HURA) stake by 3.2% in Q2 2026, selling an estimated $3.67K and leaving 47,010 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Brighton Jones LLC first reported a position in HURA in Q3 2025 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Brighton Jones LLC held 47,010 shares of TuHURA Biosciences worth $110K as of Q2 2026.
  • Brighton Jones LLC sold 1,575 TuHURA Biosciences shares in Q2 2026, an estimated $3.67K.
  • TuHURA Biosciences made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1304 holding.
  • Brighton Jones LLC first reported a position in TuHURA Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.